Keshan P. Wang
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Mitochondrial transfer: a new perspective on tumor-microenvironment crosstalk driving metastasis.
Journal: Frontiers in immunology
Published: June 28, 2026
CA9-Targeted PET Imaging for Noninvasive Discrimination of Clear Cell Renal Cell Carcinoma and Associated Tumor Biological Features.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 23, 2026
PRKAB2 as a tumor suppressor in renal cell carcinoma: inhibiting mitophagy via the LRPPRC-PRKN/parkin interaction and cardiolipin biosynthesis.
Journal: Autophagy
Published: January 30, 2026
Editorial: Gene editing in cancer gene therapy.
Journal: Frontiers in medicine
Published: January 28, 2026
The regulatory mechanism and clinical significance of RNA editing in prostate cancer.
Journal: Current urology
Published: November 27, 2025
Enhancing Triple-Negative Breast Cancer Radiotherapy via EZH2-Targeted Nanoplatform and Radionuclide Therapy.
Journal: Molecular pharmaceutics
Published: November 22, 2025
Correction: Precision scalpels for the epigenome: next-gen editing tools in targeted therapies.
Journal: Frontiers in medicine
Published: October 11, 2025
Macrophage membrane-coated nanoparticles in inflammatory diseases: from bioinspired design to translational potential.
Journal: Journal of nanobiotechnology
Published: October 06, 2025
Colorectal cancer stem cells crosstalk in tumor immune microenvironment and targeted therapeutic strategies.
Journal: Frontiers in immunology
Published: September 28, 2025
Factors influencing medical students' adoption of AI educational agents: an extended UTAUT model.
Journal: BMC medical education
Published: September 06, 2025
Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall?
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: August 01, 2025
Rationally and in silico guided APOBEC3F-directed CBE for enhanced PDAC genetic therapy.
Journal: Communications biology
Published: July 10, 2025
Last Updated: 09/26/2026